Vivi Kasim
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 11
- Cancer, Lipids, and Metabolism 7
- Cancer-related molecular mechanisms research 6
- Aging top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 12
- Epigenetics and DNA Methylation 11
- RNA Research and Splicing 6
- Biotechnology top 10%
- Physiology top 10%
-
- Cancer-related Molecular Pathways 11
-
- Lipid metabolism and disorders 6
Vivi Kasim
57 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Cancer Research 528
- Aging 45
- Molecular Biology 1.3k
- Biotechnology 91
- Physiology 253
Countries citing papers authored by Vivi Kasim
This map shows the geographic impact of Vivi Kasim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivi Kasim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivi Kasim more than expected).
Fields of papers citing papers by Vivi Kasim
This network shows the impact of papers produced by Vivi Kasim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivi Kasim. The network helps show where Vivi Kasim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vivi Kasim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The two sides of chromosomal instability: drivers and brakes in cancerbreakdown → | 2024 | 72 |
| 2 | 2024 | 8 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 34 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 17 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 40 | |
| 10 | 2022 | 27 | |
| 11 | 2020 | 92 | |
| 12 | 2020 | 20 | |
| 13 | 2019 | 22 | |
| 14 | 2019 | 25 | |
| 15 | 2019 | 19 | |
| 16 | 2018 | 115 | |
| 17 | 2018 | 19 | |
| 18 | 2017 | 44 | |
| 19 | 2015 | 13 | |
| 20 | 2013 | 67 |
About Vivi Kasim
Vivi Kasim is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 62 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA modifications and cancer (12 papers), Cancer-related Molecular Pathways (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), Epigenetics and DNA Methylation (11 papers), Cancer, Lipids, and Metabolism (7 papers), Lipid metabolism and disorders (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Cancer Research (528 citations), Aging (45 citations) and Molecular Biology (1.3k citations). Vivi Kasim has collaborated with scholars based in China, Japan and Thailand. Frequent co-authors include Shourong Wu, Makoto Miyagishi, Can Huang, Rendy Hosea, Hezhao Zhao, Yanjun Li, Mami Yasukawa, Kenkichi Masutomi, Yoshiko Maida and Naoko Okamoto. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.